To evaluate the effectiveness of intravenous immunoglobulin (IVIG) for the treatment of COVID-19-induced cytokine storm
Latest Information Update: 04 Aug 2020
At a glance
- Drugs Immune globulin (Primary) ; Hydroxychloroquine; Lopinavir/ritonavir; Ribavirin
- Indications Adult respiratory distress syndrome; COVID 2019 infections; Cytokine release syndrome; Pneumonia
- Focus Therapeutic Use
- 04 Aug 2020 New trial record
- 11 Apr 2020 Expected recruitment end date is 22nd July 2020 as per the Iranian Registry of Clinical Trials record.